Genetic Toxicology Testing Market Size, Share & Industry Analysis, By Product (Reagents & Consumables, Assays, Services), By Application (Healthcare Industry (Pharmaceutical & Biotechnology), Food Industry, Cosmetics Industry, Other Industries (Agriculture and Chemical)) And Regional Forecast, 2024-2032

Genetic toxicology testing studies the effects of various biological, physical, and chemical agents on the living organisms’ hereditary. A study of toxic effects of damage to the DNA is known as genetic toxicology. These tests are either done to find out about chromosomal damage and gene mutation. The toxicology tests are conducted on pharmaceutical impurities, agrochemicals, chemicals used in the cosmetic industry, pharmaceutical drugs and industrial chemicals.

In the R&D sector, genetic toxicology plays an important role as various tests are conducted to develop and design new drugs. These tests help in discovering new vaccines and drugs. These tests also focuses on personalized medicines and drug discovery utilizing in vitro methods. In addition to these uses, the demand for humanized animal models is also witnessing a rise, which is likely to open ample opportunities for the key players in the global genetic toxicology testing market shortly.

The growing application of genetic toxicology testing in various end-use industries such as the healthcare industry, cosmetic industry, food industry, and others drives the market growth. The growth in the food processing industry and the demand for cosmetics is expected to drive the market. The goal of R&D activities is to grow the overall chances of approval of Phase I drug candidates by increasing the acceptance of compounds in the preclinical stages. Thus, intensive research and development activities are conducted in the early stages of drug development. Thus, this is leading to the market growth. Increasing R&D investments in the early stages of drug development are also supposed to increase the use of in vivo toxicology methods before the drug reaches the expensive clinical stages. These factors are leading to a rise in demand for the genetic toxicology testing market.

However, the lack of validation in vitro models to study complex endpoints is expected to limit the market growth for genetic toxicology. Furthermore, the reluctance of regulatory authorities to consider alternative methods for proving safety and efficacy is expected to restrain the growth of this market to a certain extent.

Key Market Driver -

Increasing R&D activities of Early Toxicity detection in drugs are reasons for the growth of this market.

Key Market Restraint -

Lack of validated In-vitro models to study complex endpoints.

Market Segmentation:

Globally, the genetic toxicology testing market can be segmented on the basis of product, application, and region. Based on product, the market can be segmented into reagents and consumables, assays and services. Based on application, the market can be segmented into healthcare industry, food industry, cosmetics industry and other industries (agriculture and chemical). Geographically, the global market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa

Key Players Covered:

The major companies in the global genetic toxicology testing market report include Thermo Fisher Scientific, Inc., Charles River Laboratories International, Inc., Laboratory Corp of America Holdings, Eurofins Scientific, Merck KGaA, Gentronik Limited, Jubilant Life Sciences, Toxikon Corporation, Sotera Health LLC, MB Research Laboratories, Shanghai Medicilon Inc., and other prominent players.

Key Insights

• Key Industry Developments


• Overview of R&D Advancements in Genetic Toxicology


• Overview of Regulatory Scenario


• Impact of COVID-19 on the Genetic Toxicology Testing Market

Regional Analysis:

North America accounts for the highest share in revenue in the genetic toxicology market. This is due to the growth in development of structure-based drug designs, high academic and government investment in the research of genomics and proteomics, and the increase in adoption rate of advanced technologies in North America. Another factor that attributes to the region’s large revenue share is the presence of key players. This region is followed by Europe, Asia-Pacific, Latin America, and the Middle East, and Africa.

Asia-Pacific is projected to show highest growth rate in the forecast period. High pharmaceutical R&D expenditure and the emerging adoption of advanced technologies would create channels for the genetic toxicology testing market in this particular region.  Latin America and Middle East and Africa region are expected to grow in the forecast period, this growth will be attributed to increase in awareness among people and to slow advancements in research programs by key players in this region.

To gain extensive insights into the market, Request for Customization

Segmentation

Genetic Toxicology Testing Industry Developments

• In January 2019, Charles River entered an agreement with Toxys to offer the latter’s ToxTracker in North America.


• In February 2021, Charles River Laboratories International, Inc. acquired Cognate BioServices, Inc. which is a premier cell and gene therapy contract development and manufacturing organization